(Q40954565)

English

Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line

scientific article published on April 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Al-Omar A

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Abdou S

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

De Robertis L

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Marsura A

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Finance C

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1115-1120

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Anthracycline antibiotics in cancer therapy. Focus on drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900150-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug resistance during cancer chemotherapy--biotechnological solutions to a clinical problem

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900150-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900150-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900150-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900150-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recognition ability and cytotoxicity of some oligosaccharidylsubstituted β‐cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900150-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(99)00150-X

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40954565&oldid=1911123016"